Mass Medical Angels

About The Fund

Mass Medical Angels (MA2) is an angel network that provides seed-stage investments specifically focusing on life science and healthcare sectors. They offer funding to early-stage life-science companies, aiming to foster innovation and deliver clinical tools to the market while seeking superior returns for their investors. Their expertise lies within various subdomains such as medical devices, therapeutics, diagnostics, health services, health information technology, and research-related tools and laboratory equipment. With targeted investments ranging between $500,000 to $17,000,000, they are flexible in providing partial or entire funding rounds. They strategically collaborate with other angel groups or venture funds to fully finance the companies and ensure they are well-capitalized. MA2 is particularly interested in capital-efficient companies where their investment can significantly increase the company's valuation. This strategy is employed in hopes of achieving a target return of five times the investment within a five-year timeframe. Members of the Mass Medical Angels group are selected based on their profound expertise in the health sciences, encompassing roles as researchers, clinicians, venture capitalists, executives, consultants, engineers, bankers, and attorneys. Their commitment to supporting early-stage ventures is complemented by their network within the Boston healthcare supercluster, a leading healthcare innovation center. This network offers additional resources, including deal flow, expertise, and advisors for the companies MA2 works with. In addition, they focus on mentoring companies to attain further funding, achieve positive cash flows, or reach acquisition. Their website features sections such as About Us, Entrepreneurs, Members, Resources, Partners, Investments, and Blog, which provide insights into their operation and investment philosophy.